At the end of the latest market close, China Pharma Holdings Inc. (CPHI) was valued at $0.42. In that particular session, Stock kicked-off at the price of $0.42 while reaching the peak value of $0.48 and lowest value recorded on the day was $0.42. The stock current value is $0.47.
Recently in News on November 13, 2020, China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results. China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma,” the “Company” or “We”), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
China Pharma Holdings Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.4000 on 03/02/20, with the lowest value was $0.2368 for the same time period, recorded on 01/02/20.
China Pharma Holdings Inc. (CPHI) full year performance was 91.22%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, China Pharma Holdings Inc. shares are logging -66.54% during the 52-week period from high price, and 108.22% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.22 and $1.40.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1496490 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the China Pharma Holdings Inc. (CPHI) recorded performance in the market was 97.85%, having the revenues showcasing 28.08% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 20.71M, as it employees total of 228 workers.
China Pharma Holdings Inc. (CPHI) in the eye of market guru’s
During the last month, 2 analysts gave the China Pharma Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.4210, with a change in the price was noted -0.0334. In a similar fashion, China Pharma Holdings Inc. posted a movement of -6.65% for the period of last 100 days, recording 599,027 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CPHI is recording 0.62 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.11.
China Pharma Holdings Inc. (CPHI): Stocks Technical analysis and Trends
Raw Stochastic average of China Pharma Holdings Inc. in the period of last 50 days is set at 43.20%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 36.46%. In the last 20 days, the company’s Stochastic %K was 19.73% and its Stochastic %D was recorded 16.30%.
If we look into the earlier routines of China Pharma Holdings Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 97.85%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -33.64%, alongside a boost of 91.22% for the period of the last 12 months. The shares increased approximately by 5.28% in the 7-day charts and went down by 9.23% in the period of the last 30 days. Common stock shares were driven by 28.08% during last recorded quarter.